Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON47127
NL-OMON47127
Recruiting
Not Applicable

Development of a platform of Patient Derived Xenografts (PDX) and 2D/3D cell cultures of Soft Tissue Sarcomas (STS): Protocol to obtain tumour material from patients with (non)-metastatic sarcomas. - Sarcoma PDX

Antoni van Leeuwenhoek Ziekenhuis0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionssoft tissue sarcoma1002838910027655

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
soft tissue sarcoma
Sponsor
Antoni van Leeuwenhoek Ziekenhuis
Enrollment
40
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
Antoni van Leeuwenhoek Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • •Histologically confirmed (non\-)metastatic intermediate to high grade STS
  • •Local recurrences are allowed
  • •Age \>\= 18 years
  • •Able and willing to undergo tumor biopsies or tumour sampling during surgery
  • •Localization of sarcoma enables safe biopsy or surgery
  • •Written informed consent

Exclusion Criteria

  • •Known coagulation disorder and/or anticoagulant medication in as far it might interfere with a safe biopsy procedure (to the discretion of the treating physician and attending radiologist).
  • •Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow\-up schedule; those conditions should be discussed with the patient before registration in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS)Soft Tissue SarcomaXenograft Model2D/3D Cell Cultures
NCT02910895The Netherlands Cancer Institute40
Completed
Not Applicable
Establishment of precision medicine platform for early diagnosis of mild cognitive impairmentDiseases of the nervous system
KCT0008093Samsung Medical Center1,000
Recruiting
Not Applicable
Establishment of clinical research platform based on dementia cohort
KCT0005516Samsung Medical Center300
Recruiting
Not Applicable
Development of Novel Ex Vivo Examination Kit To Detect HER2 Protein Overexpression in Gastric Cancergastric cancer
JPRN-UMIN000031515Kyoto University Hospital100
Unknown
Not Applicable
Hyper-Personalized Medicine Using Patient Derived Xenografts (PDXovo) for Metastatic Solid TumorsKidney NeoplasmCarcinoma, Renal CellMetastatic Solid Tumor
NCT04602702Sunnybrook Health Sciences Centre50